optometryadvisor.com

You can skip this ad in 3 seconds. Case Study: Explanation: An 18-year-old Hispanic man accompanied by his mother presented for a comprehensive eye exam after receiving a recent diagnosis of Bardet-Biedl syndrome (BBS) by a geneticist. His chief complaint was blurry vision in both eyes with and without glasses. His mother reported he consistently brought materials close to his face and had trouble noticing things in his side vision at times.

Chinese herbal medicine ultrasonic atomization combined with artificial tears (ATs) significantly improves clinical symptoms of dry eye disease (DED), according to a systematic review and meta-analysis published in Clinical Ophthalmology. Although ATs supplement tear volume in DED, they are ineffective at repairing ocular surface damage or disrupting the inflammatory cascade. Some studies have reported benefits with traditional Chinese medicine (TCM) in DED.

Patient-doctor conversations should include guidance and recommendations around refractive changes post-surgery and spectacle needs, advise researchers in an Optometry and Vision Science article. A patient’s pre-surgical spectacle wear habits and identity are associated with their desired post-surgical outcomes, the researchers show. Many are hesitant to take a decision-making role in the post-surgical outcome.

Low dose atropine may have little effect on myopic progression in children with inherited retinal diseases (IRDs), according to research in Optometry & Vision Science. The exact pathophysiology of myopia in these patients is unknown, so standard protocols for myopia control in healthy children may not work for this subgroup because of differences in visual feedback and axial growth mechanisms.

Optometry Advisor Opinion: Commentary and Perspective on Medicine and Practice. This article was written by Jeffrey Sonsino, OD, who works on Federal Relations & Advocacy with the American Optometric Association. The opinions expressed in this article are his own and do not necessarily reflect the views of Optometry Advisor or Haymarket Media. Every meaningful advancement in optometry has followed the same pattern.

The presence of predominantly peripheral lesions (PPLs) and their peripheral density are predictors of diabetic retinopathy (DR) progression, according to research in the British Journal of Ophthalmology. DR is the leading cause of preventable vision loss in working adults, so early detection and disease staging are key. The use of PPLs as a biomarker could be used to identify those at a higher risk of progression.

0:52 – Intro 2:18 – Eye Care Headlines 4:31 – Keynote Interview: Nathan Lighthizer, OD 32:53 – Spotlight on Prevent Blindness Patient Advocacy Sara-Everett Brown: One of the tenants of public health is that you need to target populations that are more susceptible and highest risk with limited resources.

Patients with central and inferior visual field (VF) loss from glaucoma appear to experience greater reductions in vision-related quality of life (QoL) than those with superior or peripheral VF defects, according to findings from a review published in Optometry and Vision Science. “Greater overall VF loss is associated with poorer vision-related QoL, yet the location of damage is likely to shape how patients experience visual difficulties,” explain the study authors.

A novel spectacle lens designed to induce peripheral myopic defocus significantly slows myopia progression and axial elongation older than 24 months in children with myopia, according to study findings published in Eye. “Beyond the evident impacts on quality of life and the economic burden of optical solutions, myopia is linked to a higher risk of various health issues, including retinal detachment, myopic maculopathy, early cataract development, and strabismus,” explain the study authors.

Preservative-free 0.01% bimatoprost ophthalmic gel (PFB) demonstrates similar efficacy and safety as benzalkonium chloride (BAK)-preserved 0.01% bimatoprost ophthalmic solution (PB) for treating open-angle glaucoma (OAG) or ocular hypertension (OHT), according to results of a pooled analysis published in Clinical Ophthalmology. Bimatoprost is one of the most effective preferred first-line treatments for elevated intraocular pressure (IOP).